Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

TOMRA: INVITATION TO 3Q 2017 PRESENTATION

TOMRA's third quarter 2017 results will be released Monday 23rd of October 2017. President & CEO Stefan Ranstrand and CFO Espen Gundersen will present the results at 08:00 CET. The presentation will be held in English and take place at Thon Conference Vika Atrium, Oslo (Meeting room: Nyland). Link to the live broadcast will be available on www.tomra.com (Investor Relations section). A recorded version of the webcast will be available after the broadcast has concluded. All written materials will be made available from 07:30 CET reporting day on www.tomra.com (Investor Relations section).

Ixat Intressenter AB (publ) Notice of Extraordinary General Meeting

The shareholders of Ixat Intressenter AB (publ), corporate registration number 559002-7156, are hereby given notice to attend the Extraordinary General Meeting of Shareholders to be held at 17.00 pm on November 15, 2017 at Cabonline Group’s offices, Kungsgatan 44, Stockholm. Notice of participation Shareholders who wish to attend must be registered as a shareholder in the share register at the date of the general meeting. A shareholder who is not personally present may exercise his/her rights at the general meeting by proxy through a written, and by the shareholder signed and dated,

YIT starts the construction of new apartment buildings in Finland and CEE countries

YIT Corporation Investor News October 16, 2017 at 1:00 p.m.YIT starts self-developed apartment building projects with the value of approximately EUR 45 million in total. The projects comprise over 230 apartments in total. The start-ups were recorded in the third quarter when the start decisions were made.  The projects support YIT’s growth strategy in Finland and in the CEE countries. The project started in Mankkaa, Espoo, Finland will be completed in winter 2019. The project is located on the side of a peaceful detached house area near excellent connections and services. The project

AniCura strengthens its position within advanced veterinary care in Germany

AniCura, one of Europe’s leading providers of high-quality veterinary care for companion animals, acquires a majority stake in Tierklinik Haar in Munich. The clinic is with its 80 veterinary professionals a well-renowned provider of highly specialised veterinary care in Germany.Throughout 2017, a number of high-quality veterinary clinics in Germany have joined AniCura. With the acquisition of a majority stake in Tierklinik Haar, AniCura cements its position as a leading provider of advanced veterinary care in the country. Tierklinik Haar was founded in 2003 as the first specialised

Vestas - Transactions in connection with share buy-back programme during the period 9 – 13 October 2017

On 17 August 2017, Vestas initiated a share buy-back programme, ref. Company announcement No. 30/2017 . The programme is implemented in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (the "Safe Harbour” rules). The purpose of the programme is to adjust Vestas’ capital structure and to meet the obligations arising from share based incentive programmes to employees of Vestas. Under the programme, Vestas will buy back shares for an amount up to DKK

ADDvise repays the bond loan 2014/2019 (ISIN:SE0006245460)

ADDvise Group AB (publ) (”ADDvise” or the ”Company”) issued, in October 2014, a bond loan of maximum 100 MSEK with ISIN SE0006245460 and current outstanding amounts to 87 MSEK (the “Bond Loan”) As previously communicated, for instance in the prospectus published on September 15 regarding the Company’s bond loan of maximum 240 MSEK 2017/2022, the above- mentioned bond loan are, inter alia, intended to reduce the financing cost to better reflect the general interest rate climate. The bond loan of maximum 240 MSEK 2017/2022 run with an interest rate of 7.25 per cent while the Bond Loan runs

Bambuser signs contract with Sky News Arabia

Bambuser AB (publ) ("Bambuser" or "the Company") has signed a one year contract with Sky News Arabia, the news and current affairs channel.Bambuser has signed a one-year agreement, with the possibility of extending for an additional year, with Sky News Arabia, regarding the Company’s product Iris Dev. The value of the subscription agreement is modest, with the possibility of additional variable revenue based on usage. The agreement will be made effective from November 2017. Sky News Arabia is a joint venture between UK-based Sky plc and Abu Dhabi Media Investment Corporation (ADMIC). Sky

Vestas introduces V120-2.0/2.2 MW turbine to China

In response to customer demand for a turbine for low and ultra-low wind conditions, Vestas today officially introduced the V120-2.0/2.2 MW turbine to the Chinese market, as a build-up to China Wind Power 2017, the annual trade fair in China’s wind power industry. The V120-2.0/2.2 MW turbine combines Vestas’ industry-leading innovation with the 2 MW platform’s proven performance and will for the Chinese market be produced locally in Tianjin, offering leading annual energy production in low and ultra-low wind regimes. First deliveries are expected to start in the third quarter of 2018. The

Jays strengthens its commercial team

The Swedish audio developer Jays AB (publ) complements its commercial team with three key members in sales and business development in order to meet the market demands and build channel strategies regionally. Stockholm, Sweden, 2017-10-16 10:04 CEST (GLOBE NEWSWIRE) -- Martin Nilsson, Fredrik Sjölander och Christopher Danielsson have been employed by Jays with sales and business development as their main focus.  Martin Nilsson holds an MBA and has more than 15 years experience in sales and marketing, including the headphone industry. He comes from a position as Marketing Manager at

Beijer Ref acquires refrigeration wholesaler in South Africa

Beijer Ref AB has entered into an agreement to acquire the business of Tecsa (Pty) Ltd and its assets. The acquisition broadens the base in Southern Africa.Tecsa Pty Ltd, controlled by Westbrooke Investments and trading as TecsaReco, is a South African wholesaler that offers a wide range of products and brands within commercial and domestic refrigeration, air conditioning and spare parts for domestic appliances. Beijer Ref acquires the company for a purchase price amounting to between SEK 255 and 300 million. The variable portion of the purchase price is dependent on TecsaReco’s performance

SimCorp A/S – Share buyback program

On 24 August 2017 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 7.5m, to be executed during the period from 24 August 2017 to 31 December 2017. The following transactions have been executed under the program:     Date                 Number of shares Average Amount (DKK)

Cherry AB publishes prospectus in connection with the listing on Nasdaq Stockholm

On 13 October 2017 Cherry AB (publ) announced that Nasdaq Stockholm’s listing committee had approved Cherry AB (publ) class B shares for listing on Nasdaq Stockholm. The prospectus that has been prepared in connection with the listing has been approved and registered by the Swedish Financial Supervisory Authority and is now available on Cherry’s website, www.cherry.se .The first day of trading on Nasdaq Stockholm is Wednesday, 18 October 2017. The final day of trading on AktieTorget is Tuesday, 17 October 2017. The shares will be traded in

Karessa Pharma Holding AB announces today that they have been approved by the MPA to start a clinical study with K-03 Vardenafil buccal film

Karessa submitted an application to the Swedish Medical Products Agency on 31st of August to perform a Phase I study on healthy volunteers of male subjects. Today, the Medical Products Agency announced that they approved the application.The study is a Phase I, open, randomized, single-center study on healthy male subjects in order to determine the PK profile in the body (pharmacokinetic profile) of Vardenafil given as K-03/1 buccal film. The study consists of comparing the PK profile of four different variants of K-03/1 buccal film. Except for the evaluating of PK profile, the safety and

Global Telecom Provider Implements Clavister Virtual Solution

With a second order in Asia this year, MNOs look increasingly to the high benefits of the company’s virtual offering.Clavister, a leader in high-performance network security solutions, has received a commercial order from a pan-global telecom provider, placing the order for one of its largest Asian operations. The initial order is for 1.1MSEK with estimates of high growth year on year, based on the Clavister data charge models. According to previously communicated telecom business update, and following Clavister’s business model based on capacity, the total deal value is estimated to 20

New Volvo 7900 Electric offers greater range and flexibility

Volvo Buses is now launching a new version of its all-electric bus, the Volvo 7900 Electric. With significantly extended range and more charging options, the new Volvo 7900 Electric offers bus operators even greater flexibility.Battery capacity, in particular, has been significantly extended compared with before. The new Volvo 7900 Electric is available with a choice of 150, 200 and 250 kWh. This means that the bus can run far longer between charges, allowing it to be utilised more efficiently throughout the day. “This is a very important reinforcement of our electromobility product

Kindred Futures and Cockroach Labs Partner to Build a Next Generation Global Online Gaming Platform

Kindred Futures, the innovation arm of Kindred Group (previously Unibet Group), today announces a partnership with Cockroach Labs to develop a world leading database solution. This will allow Kindred to greatly improve the experience for its 20 million customers.As Kindred Group continues to grow its active customer base around the world, the distance from each customer’s device to the datacentres increases, resulting in potentially lower speeds, performance and reliability. By collaborating with Cockroach Labs to develop a state-of-the-art database solution, Kindred will be able to greatly

PExA recruit expert in the field of BiomarkerDiscovery

PExA AB (”PExA”) that develop and commercialise an instrument which enable researchers to collect biological material from lung in an non-invasive way to study respiratory diseases, announces the recruitment of Jörgen Östling (PhD), a senior life science researcher.  Jörgen will assume his new role as ‘Manager, Bio­chemical Analysis and Research’ by January 15, 2018.Jörgen Östling holds a PhD in microbiology and has extensive experience from proteomics and bioinformatics. He has worked more than 20 years within the pharma industry, whereof the last six years focusing on the identification

ChromoGenics’ order to deliver dynamic glass to the Swedish Energy Agency’s new headquarters completed

ChromoGenics AB (publ) has completed the order to deliver dynamic glass to the Swedish Energy Agency's newly opened headquarters in Eskilstuna. ChromoGenics’ dynamic glass, installed in the entrance to the new headquarters, will contribute to increased energy efficiency and indoor comfort.During the third quarter, ChromoGenics delivered and installed ConverLight™ dynamic glass to the Swedish Energy Agency's new headquarters in Eskilstuna, which was recently inaugurated. A building of a former metal foundry has been transformed into an activity-based office, fully adapted to the activities

Invitation – Presentation and conference call Hoist Finance third quarter 2017 report

Hoist Finance will publish its third quarter results on Thursday, 26thof October, 2017, at approximately 08.00 AM (CET). A combined presentation and conference call for investors, analysts and media will be held at 09.30 AM (CET). The report will be presented at the company office, Sturegatan 6, by Jörgen Olsson, CEO and Pontus Sardal, CFO. The presentation will also be broadcasted live at: https://tv.streamfabriken.com/hoist-finance-q3-2017 Dial-in details for the conference call: SE: +46 85 664 2666 UK: +44 20 3008 9804 US: +1 855 753 2236 To participate at the company

Husqvarna Group scales back business with large U.S. retail customer

The Consumer Brands Division of the Husqvarna Group will significantly reduce the volume of business with one of its biggest U.S. retail customers, following the strategy to focus resources on accounts with more attractive opportunities. The Division has started to adjust capacity and other measures to mitigate short-term negative financial effects. Because of the reduced volume, the Consumer Brands Division’s net sales for 2018 is expected to decline by some SEK 1 Bn compared to 2017. This will delay the operating income improvement trajectory. “We are committed to a strong, future-

Handelsbanken’s interim report for January-September 2017 will be presented on October 18

Handelsbanken will present its results for January­‑September 2017 in Stockholmon October 18, 2017, at 8:30 a.m. CET, at a meeting with the media and analysts. The interim report for January‑September 2017 will be published at 7:00 a.m. CET,on October 18, 2017. A telephone conference will be held at 11:00 a.m. CET (5:00 a.m. EST), whenRolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 203–364 5374Swedish number: +46 8–505 564 74US number: +1 855–753 2230 Instructions1.    Dial

No serious adverse effects in GLP-tox preliminary study for Temodex

Double Bond Pharmaceutical (DBP) has initiated the toxicological evaluation of the company's drug candidate against brain cancer, Temodex, as announced earlier. This study package is intended to demonstrate the safety of Temodex in the brain in rats to clarify the improved safety profile seen in previous studies. The toxicological package begins with a preliminary study followed by the major GLP study.The first animals have now been dosed in the preliminary study without observing any serious adverse effects."The preliminary results we have obtained are entirely in line with the

Capio acquires yet another hospital and radiology unit in Denmark

Capio has acquired Viborg Privathospital and MR Scanner Aarhus in an asset deal. The clinic in the city of Viborg is primarily specialized in orthopedics and general surgery while the operations at MR Scanner Aarhus comprise radiological examinations. Net sales in 2017 are estimated to MDKK 36. The acquisition is complementary to Capio’s existing opera­tions on Jutland and some synergies are expected with the units in Skørping and Aarhus.The city of Viborg is located centrally on Jutland, less than an hour’s drive from Capio’s two units in Skørping on North Jutland and in Aarhus. The

BGB324, BerGenBio's Selective First-in-Class AXL Inhibitor, Featured in 3 Clinical Presentations at 18th World Conference on Lung Cancer in Yokohama

Bergen, Norway, October 16, 2017 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors for multiple cancer indications, announces presentations on three ongoing Phase 2 clinical trials with BGB324 in lung cancer patients at the 18th World Conference on Lung Cancer in Yokohama, Japan.BGB324, a first-in-class selective Axl inhibitor, is being investigated in three Phase 2 clinical trials across the three standard-of-care treatment regimens available to patients with non-small-cell lung cancer (NSCLC): these trials seek to

There are no items matching the current filter
There are no more items matching the current filter
Back to top